Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective studyFumihiko Urabe, Takashi Ohtsuka, Minoru Nakazono et al.|Japanese Journal of Clinical Oncology|2025Cited by 6
Effect of a variant histology on the oncological outcomes of Japanese patients with upper tract urothelial carcinomas after radical nephroureterectomy: a multicenter retrospective studyTakahiro Kimura, Naoki Uchida, Fumihiko Urabe et al.|Translational Andrology and Urology|2024Cited by 5
Does age impact clinical outcomes of radical nephroureterectomy in the elderly?—results from a multicenter retrospective studyTakahiro Kimura, Mimu Ishikawa, Katsuki Muramoto et al.|Translational Andrology and Urology|2024Cited by 5
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Takahiro Kimura, Fumihiko Urabe et al.|Japanese Journal of Clinical Oncology|2025Cited by 4
Apalutamide-induced rash and relative dose intensity in metastatic castration-sensitive prostate cancer: a multicenter Japanese cohort studyFumihiko Urabe, Takahiro Kimura, Hajime Onuma et al.|Translational Andrology and Urology|2025Cited by 2